We are live on ! Find out more
MKA

M. Kulyk & Associates Portfolio holdings

AUM $613M
1-Year Est. Return 22.75%
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
+22.75%
3 Year Est. Return
+63.27%
5 Year Est. Return
+74.76%
10 Year Est. Return
AUM
$497M
AUM Growth
+$66.8M
Cap. Flow
+$34.8M
Cap. Flow %
7.01%
Top 10 Hldgs %
43.21%
Holding
118
New
8
Increased
41
Reduced
43
Closed
4

Top Sells

Rank Stock Value
1
RY icon
Royal Bank of Canada
RY
+$928K
2
AMT icon
American Tower
AMT
+$468K
3
AAPL icon
Apple
AAPL
+$290K
4
GILD icon
Gilead Sciences
GILD
+$260K
5
ASML icon
ASML
ASML
+$243K

Sector Composition

Rank Sector Weight
1 Technology 22.74%
2 Financials 13.12%
3 Consumer Discretionary 11.55%
4 Healthcare 10.03%
5 Consumer Staples 5.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MMM icon
76
3M
MMM
$94.3B
$407K 0.08%
2,975
VYM icon
77
Vanguard High Dividend Yield ETF
VYM
$82.8B
$394K 0.08%
3,072
SYK icon
78
Stryker
SYK
$130B
$388K 0.08%
1,073
NVO
79
Novo Nordisk
NVO
$209B
$365K 0.07%
3,063
-1,573
-34% -$210K
FSST
80
DELISTED
Fidelity Sustainable US Equity ETF
FSST
$363K 0.07%
13,412
-558
-4% -$14.5K
HLNE icon
81
Hamilton Lane
HLNE
$5.57B
$353K 0.07%
2,097
+8
+0.4% +$1.16K
IBM icon
82
IBM
IBM
$224B
$351K 0.07%
1,588
ETN icon
83
Eaton
ETN
$174B
$349K 0.07%
1,053
-9
-0.8% -$2.75K
MCO icon
84
Moody's
MCO
$82.7B
$341K 0.07%
719
HPQ icon
85
HP
HPQ
$27.5B
$337K 0.07%
9,392
-854
-8% -$30.1K
ADI icon
86
Analog Devices
ADI
$190B
$332K 0.07%
1,443
SHY icon
87
iShares 1-3 Year Treasury Bond ETF
SHY
$25.1B
$316K 0.06%
3,798
+62
+2% +$5.12K
VTI icon
88
Vanguard Morningstar Total Stock Market ETF
VTI
$684B
$306K 0.06%
1,081
-6
-0.6% -$1.64K
ADBE icon
89
Adobe
ADBE
$105B
$301K 0.06%
581
-41
-7% -$22.5K
VOO icon
90
Vanguard S&P 500 ETF
VOO
$1.01T
$299K 0.06%
567
+112
+25% +$56.9K
LLY icon
91
Eli Lilly
LLY
$1.06T
$295K 0.06%
333
+2
+0.6% +$1.8K
UL icon
92
Unilever
UL
$136B
$292K 0.06%
4,002
-64
-2% -$4.42K
SPTS icon
93
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
$6.11B
$282K 0.06%
9,601
TMO icon
94
Thermo Fisher Scientific
TMO
$220B
$281K 0.06%
454
-24
-5% -$14.2K
NVS icon
95
Novartis
NVS
$297B
$271K 0.05%
2,358
+28
+1% +$3.18K
BEPC icon
96
Brookfield Renewable
BEPC
$6.26B
$266K 0.05%
8,136
-715
-8% -$20.7K
TJX icon
97
TJX Companies
TJX
$178B
$252K 0.05%
2,142
-336
-14% -$38.5K
PEP icon
98
PepsiCo
PEP
$190B
$251K 0.05%
1,479
-3
-0.2% -$515
NYT icon
99
New York Times
NYT
$10.2B
$251K 0.05%
4,500
CNI icon
100
Canadian National Railway
CNI
$76.6B
$245K 0.05%
2,088

Similar funds

M. Kulyk & Associates's Q3 2024 Portfolio in Review

As of Q3 2024, M. Kulyk & Associates held 118 positions worth $497M, up 16% from $430M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

M. Kulyk & Associates deployed $34.8M of net new capital in Q3 2024, opening 8 new positions and adding to 41 existing holdings. Its largest new stake was First Citizens BancShares: 114 shares worth $210K.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Royal Bank of Canada, an estimated $928K trimmed.

  • M. Kulyk & Associates's largest Q3 2024 buy was First Citizens BancShares: 114 shares worth $210K.
  • M. Kulyk & Associates added most to Levi Strauss in Q3 2024, an estimated $20.9M increase.
  • M. Kulyk & Associates's biggest Q3 2024 reduction was Royal Bank of Canada, cutting an estimated $928K.
  • M. Kulyk & Associates fully exited ASML in Q3 2024, selling an estimated $243K.
  • M. Kulyk & Associates's ten largest holdings make up 43% of its $497M portfolio in Q3 2024.
  • M. Kulyk & Associates opened 8 new positions and closed 4 in Q3 2024.
  • M. Kulyk & Associates's portfolio value rose 16% quarter-over-quarter to $497M.

Based on M. Kulyk & Associates's 13F filing for Q3 2024, filed 7 Nov 2024.